{"id":71680,"date":"2026-08-05T00:28:00","date_gmt":"2026-08-04T16:28:00","guid":{"rendered":"https:\/\/flcube.com\/?p=71680"},"modified":"2026-08-05T00:28:01","modified_gmt":"2026-08-04T16:28:01","slug":"hunan-zonsen-peplib-biotech-secures-over-rmb-300-million-in-series-c-financing","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=71680","title":{"rendered":"Hunan Zonsen PepLib Biotech Secures Over RMB 300 Million in Series C Financing"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">In May 2026, <strong>Hunan Zonsen PepLib Biotech Inc.<\/strong> successfully completed a <strong>Series C financing round of over RMB 300 million<\/strong>, with a post-money valuation approaching <strong>RMB 5 billion<\/strong>.<\/p>\n\n\n\n<h2 id=\"h-financing-details\" class=\"wp-block-heading\">Financing Details<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Company<\/strong><\/td><td>Hunan Zonsen PepLib Biotech Inc.<\/td><\/tr><tr><td><strong>Financing Round<\/strong><\/td><td>Series C<\/td><\/tr><tr><td><strong>Amount Raised<\/strong><\/td><td>Over RMB 300 million (approximately USD 42 million)<\/td><\/tr><tr><td><strong>Post-Money Valuation<\/strong><\/td><td>Approaching RMB 5 billion<\/td><\/tr><tr><td><strong>Completion Date<\/strong><\/td><td>May 2026<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-investor-consortium\" class=\"wp-block-heading\">Investor Consortium<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Co-Lead Investors<\/strong>: Lilly Asia Ventures and CDH Investments<\/li>\n\n\n\n<li><strong>Continued Participation<\/strong>: Multiple renowned institutions<\/li>\n\n\n\n<li><strong>New Strategic Shareholder<\/strong>: Hong Kong Investment Corporation Limited (&#8220;HKIC&#8221;) through its wholly-owned investment vehicle, OG Compressor (Hong Kong) Limited<\/li>\n\n\n\n<li><strong>Strategic Value<\/strong>: HKIC brings long-term stable patient capital and global industrial ecosystem resources<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-company-profile-amp-technology-platform\" class=\"wp-block-heading\">Company Profile &amp; Technology Platform<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Since its inception, Zonsen PepLib has been deeply committed to the discovery and development of peptide-based new drugs, and has established a comprehensive technology system for peptide drug molecular discovery and preclinical development. The company has built significant strengths in cutting-edge fields including:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Radionuclide Drug Conjugates (RDC)<\/strong><\/li>\n\n\n\n<li><strong>Peptide-Drug Conjugates (PDC)<\/strong><\/li>\n\n\n\n<li><strong>Peptide-Oligonucleotide Conjugates (POC)<\/strong><\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">The company has laid out a pipeline of <strong>over 50 innovative drug programs<\/strong> spanning multiple therapeutic areas.<\/p>\n\n\n\n<h2 id=\"h-strategic-partnerships-amp-commercial-success\" class=\"wp-block-heading\">Strategic Partnerships &amp; Commercial Success<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">In early 2026, the company entered into global licensing and collaboration agreements with multinational corporations including <strong>Eli Lilly<\/strong> and <strong>Novartis<\/strong> for its peptide pipeline assets, securing:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Upfront payments exceeding USD 50 million<\/strong><\/li>\n\n\n\n<li><strong>Potential additional milestone payments and royalties<\/strong><\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-future-strategic-direction\" class=\"wp-block-heading\">Future Strategic Direction<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Looking ahead, Zonsen PepLib will continue to deepen its strategic collaboration with HKIC to advance frontier technologies in peptide-based innovative drugs and accelerate the delivery of innovative products to the market.<\/p>\n\n\n\n<h2 id=\"h-market-context-amp-competitive-positioning\" class=\"wp-block-heading\">Market Context &amp; Competitive Positioning<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Global Peptide Therapeutics Market<\/strong>: Projected to exceed USD 56 billion by 2028<\/li>\n\n\n\n<li><strong>Competitive Advantage<\/strong>: Proprietary peptide library technology and comprehensive discovery platform<\/li>\n\n\n\n<li><strong>Strategic Positioning<\/strong>: Strong partnerships with global pharmaceutical leaders validate technology platform<\/li>\n\n\n\n<li><strong>Commercial Potential<\/strong>: Diversified pipeline across multiple conjugate modalities (RDC, PDC, POC)<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-company-statement\" class=\"wp-block-heading\">Company Statement<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">&#8220;This Series C financing represents a pivotal milestone for our organization,&#8221; said a company spokesperson. &#8220;The overwhelming support from our investors validates our innovative approach to peptide drug discovery and provides the necessary resources to advance our clinical programs and scale our operations globally.&#8221;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward-looking statements regarding financing, business development, and commercial expectations. Actual results may differ due to market dynamics, competitive pressures, partnership execution, and other risk factors.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>In May 2026, Hunan Zonsen PepLib Biotech Inc. successfully completed a Series C financing round&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[7,10],"tags":[20,4543],"class_list":["post-71680","post","type-post","status-publish","format-standard","hentry","category-company","category-deals","tag-finance","tag-zonsen-peplib-biotech"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v28.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Hunan Zonsen PepLib Biotech Secures Over RMB 300 Million in Series C Financing - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"In May 2026, Hunan Zonsen PepLib Biotech Inc. successfully completed a Series C financing round of over RMB 300 million, with a post-money valuation approaching RMB 5 billion.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=71680\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hunan Zonsen PepLib Biotech Secures Over RMB 300 Million in Series C Financing\" \/>\n<meta property=\"og:description\" content=\"In May 2026, Hunan Zonsen PepLib Biotech Inc. successfully completed a Series C financing round of over RMB 300 million, with a post-money valuation approaching RMB 5 billion.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=71680\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-04T16:28:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-04T16:28:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=71680#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=71680\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Hunan Zonsen PepLib Biotech Secures Over RMB 300 Million in Series C Financing\",\"datePublished\":\"2026-08-04T16:28:00+00:00\",\"dateModified\":\"2026-08-04T16:28:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=71680\"},\"wordCount\":391,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"Finance\",\"Zonsen PepLib Biotech\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=71680#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=71680\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=71680\",\"name\":\"Hunan Zonsen PepLib Biotech Secures Over RMB 300 Million in Series C Financing - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-08-04T16:28:00+00:00\",\"dateModified\":\"2026-08-04T16:28:01+00:00\",\"description\":\"In May 2026, Hunan Zonsen PepLib Biotech Inc. successfully completed a Series C financing round of over RMB 300 million, with a post-money valuation approaching RMB 5 billion.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=71680#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=71680\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=71680#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hunan Zonsen PepLib Biotech Secures Over RMB 300 Million in Series C Financing\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Hunan Zonsen PepLib Biotech Secures Over RMB 300 Million in Series C Financing - Insight, China&#039;s Pharmaceutical Industry","description":"In May 2026, Hunan Zonsen PepLib Biotech Inc. successfully completed a Series C financing round of over RMB 300 million, with a post-money valuation approaching RMB 5 billion.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=71680","og_locale":"en_US","og_type":"article","og_title":"Hunan Zonsen PepLib Biotech Secures Over RMB 300 Million in Series C Financing","og_description":"In May 2026, Hunan Zonsen PepLib Biotech Inc. successfully completed a Series C financing round of over RMB 300 million, with a post-money valuation approaching RMB 5 billion.","og_url":"https:\/\/flcube.com\/?p=71680","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-08-04T16:28:00+00:00","article_modified_time":"2026-08-04T16:28:01+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=71680#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=71680"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Hunan Zonsen PepLib Biotech Secures Over RMB 300 Million in Series C Financing","datePublished":"2026-08-04T16:28:00+00:00","dateModified":"2026-08-04T16:28:01+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=71680"},"wordCount":391,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["Finance","Zonsen PepLib Biotech"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=71680#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=71680","url":"https:\/\/flcube.com\/?p=71680","name":"Hunan Zonsen PepLib Biotech Secures Over RMB 300 Million in Series C Financing - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-08-04T16:28:00+00:00","dateModified":"2026-08-04T16:28:01+00:00","description":"In May 2026, Hunan Zonsen PepLib Biotech Inc. successfully completed a Series C financing round of over RMB 300 million, with a post-money valuation approaching RMB 5 billion.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=71680#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=71680"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=71680#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Hunan Zonsen PepLib Biotech Secures Over RMB 300 Million in Series C Financing"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/71680","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=71680"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/71680\/revisions"}],"predecessor-version":[{"id":71681,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/71680\/revisions\/71681"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=71680"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=71680"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=71680"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}